Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression

Journal of Psychiatric Research

Volumn 46, Issue 3, 2012, Pages 285-289

  Birkenhäger, Tom K ^a   Geldermans, Sarah ^a   Van Den Broek, Walter W ^a   van Beveren, Nico ^a   Fekkes, Durk ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brain derived neurotrophic factor; Hamilton rating scale for depression; Major depression; Psychotic features

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA;

EID: 84857138796     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.12.006     Document Type: Article

References (25)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 1999, 20:59-61.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
3. Aydemir O., Deveci A., Taskin O.E., Taneli F., Esen-Danaci A. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry 2007, 31:1023-1026.
4. Barrientos R.M., Sprunger D.B., Campeau S., Higgins E.A., Watkins L.R., Rudy J.W., et al. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 2003, 121:847-853.
5. Bech P., Kastrup M., Rafaelsen O.J. Mini-compendium of rating scales for states of anxiety, depression, mania and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatrica Scandinavica 1986, 326:23-28. Suppl.
6. van Beveren N.J., van der Spelt J.J., de Haan L., Fekkes D. Schizophrenia-associated neural growth factors in peripheral blood. A review. European Neuropsychopharmacology 2006, 16:469-480.
7. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 2001, 50:260-265.
8. Dell'Osso L., Carnassi C., Del Debbio A., Catena Dell'Osso M., Bianchi C., Da Pozzo E., et al. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry 2009, 33:899-902.
9. Dell'Osso L., Del Debbio A., Veltri A., Bianchi C., Roncaglia I., Carlini M., et al. Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients. Neuropsychobiology 2010, 62:207-212.
10. Diniz B.S., Texeira A.L., Talib L.L., Mendonca V.A., Gattaz W.F., Forlenza O.V. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. The World Journal of Biological Psychiatry 2010, 11:550-555.
11. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thrombosis and Haemostasis 2002, 87:728-734.
12. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor (BDNF) levels in major depressed patients. Psychiatry Research 2002, 109:143-148.
13. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. Journal of Affective Disorders 2007, 101:239-244.
14. Lewin G.R., Barde Y.A. Physiology of neurotrophins. Annual Review of Neuroscience 1996, 19:289-317.
15. Machado-Vieira R., Dietrich M.O., Leke R., Cereser V.H., Zanatto V., Kapczinski F, et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biological Psychiatry 2007, 61:142-144.
16. McEwen B.S. Stress and hippocampal plasticity. Annual Review of Neuroscience 1999, 22:105-122.
17. Pan W., Banks W.A., Fasold M.B., Blunth J., Kasten A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
18. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences 2008, 31:464-468.
19. Post R.M. The role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research 2007, 41:979-990.
20. Rasmusson A.M., Shi L., Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associatedwith footshock. Neuropsychopharmacology 2002, 27:133-142.
21. Rosenfeld R.D., Zeni L., Haniu M., Talvenheimo J., Radka S.F., Bennett L., et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expression and Purification 1995, 6:465-471.
22. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-532.
23. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003, 54:70-75.
24. Smith M.A., Makino S., Kvetnansky R., Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Annals of the New York Academy of Sciences 1995, 771:234-239.
25. Spitzer R.L., Endicott J. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35:837-844.